Five blood tests that make prevention more concrete

The takeaway

Preventive blood testing can make prevention less abstract. Five useful categories are lipoprotein(a), a lipid panel, HbA1c, kidney function markers, and a full blood count. The point is not to create anxiety around lab numbers. It is to catch risk signals early enough that a clinician can interpret them in context.

The heart-risk tests

Lipoprotein(a), often written as Lp(a), is largely genetic. That makes it different from many other blood markers. Diet and exercise may be excellent for overall health, but they usually do not change Lp(a) very much. Consensus statements explain why some guidelines suggest measuring it at least once in adulthood.

The second test is a lipid or cholesterol panel. Cholesterol itself is not "bad"; the body needs it. The risk conversation is about the lipoprotein particles that carry cholesterol through the blood, especially LDL-related particles and ApoB-containing particles. A standard lipid panel can start that conversation, and some people may need more detailed interpretation.

The metabolism and kidney checks

HbA1c reflects average blood sugar over roughly the previous two to three months. It is commonly used to identify diabetes or prediabetes patterns. The practical value is that HbA1c can reveal a trend before symptoms force attention.

Kidney function markers, including sodium, potassium, and creatinine, act like dashboard lights. They can point toward filtering problems, electrolyte issues, dehydration, medication effects, or other concerns that need a clinician's interpretation.

The broad screen

A full blood count looks at red blood cells, white blood cells, and platelets. It can reveal anemia patterns, infection signals, immune changes, or platelet abnormalities. It is not a diagnosis by itself, but it can show that a closer look is warranted.

This article is an editorial summary of the cited research. It is not medical advice, and lab testing decisions should be made with a qualified clinician.

Sources

1. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies
3. Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors
4. Cholesterol: from where does it come, how does it circulate, where does it go?
5. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials